|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0546 | ED148685 | General Research Use | No | Female | White | 80 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0605 | ED148280 | General Research Use | No | Female | White | 59 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0684 | ED149506 | General Research Use | No | Female | White | 75 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1126 | ED148530 | General Research Use | No | Male | White | 80 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1177 | ED148176 | General Research Use | No | Male | White | 70 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1270 | ED149341 | General Research Use | No | Female | White | 74 | 6 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1643 | ED149418 | General Research Use | No | Female | White | 78 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1697 | ED149776 | General Research Use | No | Male | White | 70 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2124 | ED148811 | General Research Use | No | Female | White | 65 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2269 | ED148566 | General Research Use | No | Male | White | 67 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2397 | ED149737 | General Research Use | No | Female | White | 78 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3181 | ED149028 | General Research Use | No | Female | White | 70 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3285 | ED150002 | General Research Use | No | Male | White | 82 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3305 | ED148295 | General Research Use | No | Female | White | 60 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3451 | ED149046 | General Research Use | No | Female | Other | 74 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3908 | ED148403 | General Research Use | No | Female | White | 65 | 6 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0330 | ED149567 | General Research Use | No | Female | White | 68 | 6 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0561 | ED148304 | General Research Use | No | Male | White | 63 | 4 - AREDS AMD Severity Scale Step 1 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0723 | ED148593 | General Research Use | No | Male | White | 64 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0745 | ED148942 | General Research Use | No | Female | White | 78 | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 7 - AREDS AMD Severity Scale Step 7 |